HIGHLIGHTS
- who: ERAD et al. from the Université de Brest, Brest, France Department of Biochemistry and Biotechnology, University of Thessaly, Viopolis, Larissa, Greece have published the research: The Expression of Myeloproliferative, in the Journal: (JOURNAL)
- what: The authors propose that this network could be considered Cancers 1921; __NEWPAGE__Cancers of as a potential therapeutic target for selectively inhibiting CALR mutant-dependent proliferation associated with and therefore attenuate the associated pathogenic outcomes. The authors show that expression of CALR variants in various cell culture models does not significantly disturb ER homeostasis. Collectively, the authors show that CALR variants . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.